References

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR∗D report

10.1176/ajp.2006.163.11.1905 · 2006 · External reference

Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: A randomised, double-blind, placebo-controlled trial

10.1016/s0140-6736(15)00308-6 · 2015 · External reference

The antidepressant-like effect of human opiorphin via opioid-dependent pathways in mice

10.1016/j.neulet.2010.12.002 · 2011 · External reference

Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain

10.1016/0306-4522(95)00154-b · 1995 · External reference

Association of beta-endorphin with specific clinical symptoms of depression

10.1176/ajp.149.9.1162 · 1992 · External reference

Serum β-endorphin level in patients with depression on fluvoxamine

10.1016/s0014-827x(99)00005-1 · 1999 · External reference

Aging and the hypothalamo-pituitary-testicular axis in the rat

10.1016/0022-4731(87)90140-3 · 1987 · External reference

Opiate receptor characteristics in brains from young, mature and aged mice

10.1016/s0197-4580(88)80066-6 · 1988 · External reference

Distribution of kappa opioid receptors in the brain of young and old male rats

10.1016/0024-3205(89)90073-8 · 1989 · External reference

Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats

10.1016/s0024-3205(02)02220-8 · 2002 · External reference

Dynorphin, stress, and depression

10.1016/j.brainres.2009.09.074 · 2010 · External reference

Antidepressant-like effects of the novel kappa opioid antagonist MCL-144B in the forced-swim test

10.1159/000112867 · 2008 · External reference

Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults

10.4088/jcp.13m08725 · 2014 · External reference

Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: A randomized controlled trial [published correction appears in Am J Psychiatry 2016; 173:198]

10.1176/appi.ajp.2015.15040535 · 2016 · External reference

Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: Two randomized controlled studies

10.1038/s41380-018-0284-1 · 2020 · External reference

Cure therapeutics and strategic prevention: Raising the bar for mental health research

10.1038/sj.mp.4001777 · 2006 · External reference

FMRI visualization of brain activity during a monetary incentive delay task

10.1006/nimg.2000.0593 · 2000 · External reference

Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depression

10.1016/j.nicl.2019.101679 · 2019 · External reference

Buprenorphine treatment of refractory depression

10.1097/00004714-199502000-00008 · 1995 · External reference

Assessment of suicidal intention: The Scale for Suicide Ideation

10.1037/0022-006x.47.2.343 · 1979 · External reference

Adverse reactions to antidepressants

10.1192/bjp.bp.108.061960 · 2009 · External reference

Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale

10.1016/0165-1781(92)90005-n · 1992 · External reference

Differential effects of acute stress on anticipatory and consummatory phases of reward processing

10.1016/j.neuroscience.2014.01.058 · 2014 · External reference

The neural correlates of reward-related processing in major depressive disorder: A meta-analysis of functional magnetic resonance imaging studies

10.1016/j.jad.2013.06.039 · 2013 · External reference

Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging

10.2967/jnumed.112.109512 · 2013 · External reference

Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor

10.2967/jnumed.114.147975 · 2015 · External reference

Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans

10.1038/jcbfm.2014.150 · 2014 · External reference

FreeSurfer

10.1016/j.neuroimage.2012.01.021 · 2012 · External reference

Non-invasive magnetic stimulation of human motor cortex

10.1016/s0140-6736(85)92413-4 · 1985 · External reference

Focal stimulation of human cerebral cortex with the magnetic coil: A comparison with electrical stimulation

10.1016/0168-5597(89)90029-4 · 1989 · External reference

State of the art: Physiology of transcranial motor cortex stimulation

10.1016/j.brs.2008.07.004 · 2008 · External reference

Corticocortical inhibition in human motor cortex

10.1113/jphysiol.1993.sp019912 · 1993 · External reference

State of the art: Pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation

10.1016/j.brs.2008.06.002 · 2008 · External reference

Consensus: Motor cortex plasticity protocols

10.1016/j.brs.2008.06.006 · 2008 · External reference

Induction of plasticity in the human motor cortex by paired associative stimulation

10.1093/brain/123.3.572 · 2000 · External reference

Endogenous opioid system dysregulation in depression: Implications for new therapeutic approaches

10.1038/s41380-018-0117-2 · 2019 · External reference

Brain opioid receptor adaptation and expression after prenatal exposure to buprenorphine

10.1016/s0165-3806(98)00117-5 · 1998 · External reference

Neuroplasticity in depressed individuals compared with healthy controls

10.1038/npp.2013.126 · 2013 · External reference

A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders

10.1016/j.clinph.2013.01.014 · 2013 · External reference

Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling

10.1016/j.biopsych.2011.11.015 · 2012 · External reference

Cortical inhibition, facilitation and plasticity in late-life depression: Effects of venlafaxine pharmacotherapy

10.1503/jpn.200001 · 2021 · External reference

Effects of ascending buprenorphine doses on measures of experimental pain: A pilot study

10.1016/j.jsat.2019.07.002 · 2019 · External reference